A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new ...
Mar 1, 2021
0
89
The list of diseases and conditions complicated by obesity is a long one; it includes heart disease, cancer, diabetes and impaired wound healing, as well as skin infections. It is not always clear, however, in what way this ...
No story in biology is more intriguing than the one involving B cells and the intricate processes that result in antibody production—it's a story about mathematics, a tale of genetics and a saga of how vast armies of tiny ...
How does SARS-CoV-2 evade our immune defenses? It's a good question, actually. When SARS-CoV-2 defeats host defenses, we need to know how it does so, and conversely, when host defenses prevail, that also needs to be understood. ...
Toxins, radiation, and normal metabolic processes together generate molecular lesions in every one of our cells to the tune of 10,000 to 1,000,000 hits per day. Fortunately, most of these code faults are immediately patched ...
To effectively combat an infection, the body first has to sense it's been invaded, then the affected tissue must send out signals to corral resources to fight the intruder. Knowing more about these early stages of pathogen ...
Dec 28, 2020
0
378
Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial ...
Dec 23, 2020
0
434
Autoinflammatory syndromes are often the result of genetic mutations that ultimately compromise neutrophils, macrophages and other cells of the innate immune system. Rather than showering sufferers with broad immunosuppressives, ...
Inadequate development of new antibiotics and rising rates of resistance by bacteria to existing antimicrobials are dual forces pushing the world ever closer to a post-antibiotic era.
Mobile medical microrobots can now be engineered in the lab for broad ranging applications from personalized disease treatment to targeted drug delivery. During their structural design, bioengineers aim to minimize physical ...
